Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
Clicks: 380
ID: 79208
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
66.6
/100
380 views
257 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #60 of 432 articles by views in The Journal of infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear.We conducted a one-stage individual participant data (IPD) meta-analysis exploring the association between NAI treatment and LoS in patients hospitalized with 2009 influenza A(H1N1) virus (A[H1N1]pdm09) infection. Using mixed-effects negative binomial regression and adjusting for the propensity to receive NAI, antibiotic, and corticosteroid treatment, we calculated incidence rate ratios (IRRs) and 95% confidence intervals (CIs). Patients with a LoS of <1 day and those who died while hospitalized were excluded.We analyzed data on 18 309 patients from 70 clinical centers. After adjustment, NAI treatment initiated at hospitalization was associated with a 19% reduction in the LoS among patients with clinically suspected or laboratory-confirmed influenza A(H1N1)pdm09 infection (IRR, 0.81; 95% CI, .78-.85), compared with later or no initiation of NAI treatment. Similar statistically significant associations were seen in all clinical subgroups. NAI treatment (at any time), compared with no NAI treatment, and NAI treatment initiated <2 days after symptom onset, compared with later or no initiation of NAI treatment, showed mixed patterns of association with the LoS.When patients hospitalized with influenza are treated with NAIs, treatment initiated on admission, regardless of time since symptom onset, is associated with a reduced LoS, compared with later or no initiation of treatment.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (82 words).
Try re-searching for a better abstract.
| Reference Key |
venkatesan2019neuraminidasethe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Venkatesan, Sudhir;Myles, Puja R;Bolton, Kirsty J;Muthuri, Stella G;Al Khuwaitir, Tarig;Anovadiya, Ashish P;Azziz-Baumgartner, Eduardo;Bajjou, Tahar;Bassetti, Matteo;Beovic, Bojana;Bertisch, Barbara;Bonmarin, Isabelle;Booy, Robert;Borja-Aburto, Victor H;Burgmann, Heinz;Cao, Bin;Carratala, Jordi;Chinbayar, Tserendorj;Cilloniz, Catia;Denholm, Justin T;Dominguez, Samuel R;Duarte, Pericles A D;Dubnov-Raz, Gal;Fanella, Sergio;Gao, Zhancheng;Gérardin, Patrick;Giannella, Maddalena;Gubbels, Sophie;Herberg, Jethro;Higuera Iglesias, Anjarath Lorena;Hoeger, Peter H;Hu, Xiao Yun;Islam, Quazi T;Jiménez, Mirela F;Keijzers, Gerben;Khalili, Hossein;Kusznierz, Gabriela;Kuzman, Ilija;Langenegger, Eduard;Lankarani, Kamran B;Leo, Yee-Sin;Libster, Romina P;Linko, Rita;Madanat, Faris;Maltezos, Efstratios;Mamun, Abdullah;Manabe, Toshie;Metan, Gokhan;Mickiene, Auksė;Mikić, Dragan;Mohn, Kristin G I;Oliva, Maria E;Ozkan, Mehpare;Parekh, Dhruv;Paul, Mical;Rath, Barbara A;Refaey, Samir;Rodríguez, Alejandro H;Sertogullarindan, Bunyamin;Skręt-Magierło, Joanna;Somer, Ayper;Talarek, Ewa;Tang, Julian W;To, Kelvin;Tran, Dat;Uyeki, Timothy M;Vaudry, Wendy;Vidmar, Tjasa;Zarogoulidis, Paul;, ;Nguyen-Van-Tam, Jonathan S; |
| Journal | The Journal of infectious diseases |
| Year | 2019 |
| DOI |
jiz152
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.